GABRIELLA EBERS: Open Payments
NPI 1265194831 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,920 in 88 payments from 17 companies in 2025. Trend: 2023 $1,839 · 2024 $2,128 · 2025 $1,920
Food & beverage: $1,750Education: $170
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $305 |
| ABBVIE INC. | 25 | $291 |
| E.R. Squibb & Sons, L.L.C. | 15 | $203 |
| Incyte Corporation | 6 | $200 |
| Mallinckrodt Hospital Products Inc. | 3 | $181 |
| Novartis Pharmaceuticals Corporation | 6 | $123 |
| UCB, Inc. | 5 | $101 |
| Lilly USA, LLC | 4 | $86 |
| Janssen Biotech, Inc. | 3 | $74 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
Products named: DUPIXENT, Sotyktu, OPZELURA, ACTHAR, RINVOQ, SKYRIZI, COSENTYX, Bimzelx.
Industry payments across MO — which companies pay providers there.
